Update of the Belgian Association for the Study of the Liver Guidelines for the Treatment of Chronic Hepatitis C Genotype 1 with Protease Inhibitors

被引：0
|
作者：
Orlent, Hans [1 ]
Deltenre, Pierre [2 ]
Francque, Sven [3 ]
Laleman, Wim [4 ]
Moreno, Christophe [5 ]
Bourgeois, Stefan [6 ]
Colle, Isabelle [7 ]
Delwaide, Jean [8 ]
De Maeght, Stephane [2 ]
Mulkay, Jean-Pierre [9 ]
Starkel, Peter [10 ]
Reynaert, Hendrik [11 ]
机构：
[1] AZ St Jan AV Brugge Oostende, Dept Gastroenterol & Hepatol, Brugge, Belgium
[2] Hop Jolimont, Serv Hepatogastroenterol, Haine St Paul, Belgium
[3] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium
[4] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Dept Liver & Biliopancreat Disorders, B-3000 Louvain, Belgium
[5] Univ Libre Bruxelles, Erasme Hosp, Dept Gastroenterol & Hepatopancreatol, Brussels, Belgium
[6] AZ Stuivenberg, Dept Gastroenterol, Antwerp, Belgium
[7] Ghent Univ Hosp, Dept Gastroenterol & Hepatol, Ghent, Belgium
[8] Univ Liege, CHU Sart Tilman, Dept Gastroenterol, Liege, Belgium
[9] CHU St Pierre, Dept Hepatogastroenterol, Brussels, Belgium
[10] Clin Univ St Luc UCL, Serv Hepatol, Woluwe St Lambert, Belgium
[11] UZ Brussels, Dept Gastroenterol & Hepatol, Brussels, Belgium
来源：
ACTA GASTRO-ENTEROLOGICA BELGICA | 2012年 / 75卷 / 02期
关键词：
SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-NAIVE PATIENTS; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; COMBINATION THERAPY; ANTIVIRAL THERAPY; INTERFERON-ALPHA; SVR RATES; HCV-RNA; VIRUS;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：245 / 259
页数：15
相关论文
共 50 条
  • [31] ASSOCIATION OF SERUM ADIPOCYTOKINES WITH LIVER INJURY IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4
    Khattab, M.
    Shatat, M.
    Eslam, M.
    Mayada, A.
    Hussein, A.
    Gaber, S.
    Harrison, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S458 - S459
  • [32] Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia
    Atta, Maria
    Cabral, Milena
    Santos, Gilvan
    Parana, Raymundo
    Atta, Ajax
    INFLAMMATION RESEARCH, 2012, 61 (10) : 1101 - 1106
  • [33] The role of triple therapy with protease inhibitors in hepatitis C virus genotype 1 naive patients
    Nelson, David R.
    LIVER INTERNATIONAL, 2011, 31 : 53 - 57
  • [34] Hepatitis C treatment and progression of liver stiffness in Australia, subsequent to the introduction of protease inhibitors
    Wu, Y.
    Weltman, M.
    Eslick, G. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 100 - 100
  • [35] Treatment of chronic hepatitis C, genotype 4
    Ferenci P.
    Current Hepatitis Reports, 2013, 12 (4) : 246 - 250
  • [36] Hepatitis C treatment and Progression of Liver Stiffness in Australia, subsequent to the introduction of protease inhibitors
    Wu, Yang
    Chen, Hank H.
    Weltman, Martin
    Eslick, Guy D.
    Jideh, Bilel
    Pokorski, Izabella
    HEPATOLOGY, 2015, 62 : 917A - 917A
  • [37] A RETROSPECTIVE COMPARATIVE STUDY OF PEGYLATED INTERFERON AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 6 AND GENOTYPE 1
    Tsang, Owen T.
    Zee, Janpaul
    Chan, Jacky
    Li, Reggie S.
    Lai, Jak Yiu
    Lai, Thomas S.
    HEPATOLOGY, 2008, 48 (04) : 884A - 884A
  • [38] An update on the toxicological considerations for protease inhibitors used for hepatitis C infection
    Mak, Lung-Yi
    Seto, Wai-Kay
    Lai, Ching-Lung
    Yuen, Man-Fung
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2018, 14 (05) : 483 - 491
  • [39] Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines
    Coffin, Carla S.
    Fung, Scott K.
    Ma, Mang M.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (12) : 917 - 938
  • [40] NS3 protease inhibitors for treatment of chronic hepatitis C: Efficacy and safety
    Igor Bakulin
    Victor Pasechnikov
    Anna Varlamicheva
    Irina Sannikova
    World Journal of Hepatology, 2014, (05) : 326 - 339
12345